Home > Notices & Highlights > News details

International Pharmaceutical Business School and Shandong Elohim Pharmaceutical signed a strategic cooperation agreement


In order to strengthen school-enterprise-depth cooperation, integration advantages of resources, August 6 to 9, President of the International Pharmaceutical Business School Maai Xia, party secretary Yu Guangzhou Cong, vice president Ding Jinxi, deputy party secretary of Fang Fang and other college teachers led a delegation to Shandong Elohim Pharmaceutical Group Co., Ltd. were visits to research.

During Elohim Pharmaceutical Group General Manager Miss Li Minghua and business school leaders on multiple projects Pharmacoeconomic evaluation, international registration of intellectual property and personnel training and other pharmaceutical signed a preliminary strategic cooperation agreement. School teaching and research team each respectively Elohim Pharmaceutical Quality Management, Production, Supply Department, business management, engineering management department, research centers and other department heads and middle managers to evaluate drug quality consistency, quality management, development status and the actual demand of production process management, product marketing, brand building, pharmaceutical raw materials overseas market development, personnel training and other areas of medicine policy conducted in-depth exchanges and discussions, and complete pharmacy-related professional training school system and curriculum research work.

The exchange is a key step in business schools and business school strategic cooperation, not only received a good corporate feedback to improve the influence of school, but also further open up a new situation in schools and all-round cooperation of pharmaceutical companies.

Shandong Elohim Pharmaceutical Group Co., Ltd. is a modern pharmaceutical production, sale, trade, scientific research in one, with three manufacturing base, more than 50 production lines and 47 national drug. Since December 2005 listed in Hong Kong H-share listing has repeatedly been rated as Chinese pharmaceutical industry hundred enterprises, the top ten pharmaceutical companies in most of the growth, China's outstanding private technology enterprises, is a national key high-tech enterprises.